Tourette Syndrome Global Clinical Trials Review, H2, 2014

GlobalData
July 31, 2014
72 Pages - SKU: GBDT5314030
Countries covered: Global

Tourette Syndrome Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Tourette Syndrome Global Clinical Trials Review, H2, 2014 provides data on the Tourette Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tourette Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tourette Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companie.



More CNS/Neurology reports by GlobalData

Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014 by GlobalData
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014 provides data ...
Seizures Global Clinical Trials Review, H2, 2014 by GlobalData
Seizures Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Seizures Global Clinical Trials Review, H2, 2014 provides data on the Seizures clinical trial scenario. ...
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2014 by GlobalData
Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Seasonal Affective Disorder (SAD) Global Clinical Trials Review, H2, 2014 provides data ...
Schizoaffective Disorder Global Clinical Trials Review, H2, 2014 by GlobalData
Schizoaffective Disorder Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Schizoaffective Disorder Global Clinical Trials Review, H2, 2014 provides data on the Schizoaffective Disorder ...
See all reports like this >>

More Global CNS/Neurology reports

Tourette Syndrome Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 by DelveInsight
Tourette Syndrome Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014SUMMARYDelveInsight’s, “ Tourette Syndrome- Market Analysis, Global API Manufacturers and Phase III ...
Social Anxiety Disorders (SAD) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 by DelveInsight
Social Anxiety Disorders (SAD) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014SUMMARYDelveInsight’s, “ Social Anxiety Disorders (SAD)- Market Analysis, Global API ...
Recurrent Glioblastoma Multiforme (GBM) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 by DelveInsight
Recurrent Glioblastoma Multiforme (GBM) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014SUMMARYDelveInsight’s, “ Recurrent Glioblastoma Multiforme (GBM)- Market Analysis, Global API ...
Narcolepsy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014 by DelveInsight
Narcolepsy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014SUMMARYDelveInsight’s, “ Narcolepsy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 2,500  
    Site License  USD 5,000  
    Global Site License  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!